Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
ADF GROUP SBVTG (TSX: DRX)
1.410 CAD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:40 AM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News
Stories about ADF GROUP SBVTG
 
< Previous 1 2 3 4 5 Next >
Royalty Pharma drops hostile bid for Elan
June 18, 2013
Royalty Pharma's hostile $8 billion bid for Irish drug firm Elan lapsed on Tuesday when it withdrew an appeal against a ruling by Ireland's regulator on takeover battles. Read More
from FOX News
Royalty Pharma drops hostile bid for Elan
June 18, 2013
DUBLIN, June 18 (Reuters) - Royalty Pharma's hostile $8 billion bid for Irish drug firm Elan lapsed on Tuesday when it withdrew an appeal against a ruling by Ireland's regulator on takeover battles. Read More
category companyNews
from Reuters: Company News
Court Appoints Lead Plaintiff in Shareholder Lawsuit Against SAC
June 17, 2013
A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan against SAC Capital. Read More
from FOX News
Court appoints lead plaintiff in shareholder lawsuit against SAC
June 17, 2013
June 18 (Reuters) - A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan Corp against SAC Capital, a court filing showed, as the hedge fund... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Royalty hostile bid for Elan in doubt after vote
June 17, 2013
DUBLIN, June 17 (Reuters) - Elan shareholders approved a share buyback on Monday, meaning U.S.-based Royalty Pharma's hostile bid for the Irish drug firm will lapse unless it succeeds in a legal... Read More
category companyNews
from Reuters: Company News
Elan shareholders approve buyback in blow to Royalty bid
June 17, 2013
Elan shareholders approved a share buyback on Monday, meaning U.S.-based Royalty Pharma's hostile bid for the Irish drug firm will lapse unless a legal challenge it has mounted succeeds. Read More
from FOX News
Elan shareholders approve buyback in blow to Royalty bid
June 17, 2013
DUBLIN, June 17 (Reuters) - Elan shareholders approved a share buyback on Monday, meaning U.S.-based Royalty Pharma's hostile bid for the Irish drug firm will lapse unless a legal challenge it has... Read More
category companyNews
from Reuters: Company News
BRIEF-RP Management says Elan sales process offers shareholders no certainty
June 14, 2013
LONDON, June 14 (Reuters) - RP Management: * RP Management - Royalty Pharma notes Elan sales process offers shareholders Read More
category companyNews
from Reuters: Company News
US STOCKS-Wall St little changed, investors wary on policy path
June 14, 2013
NEW YORK, June 14 (Reuters) - Wall Street was little changed on Friday as investors were kept on their heels by uncertainty over how soon central banks will rein in the stimulus programs that have... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Irish drug firm Elan puts itself up for sale
June 14, 2013
* Elan has attracted interest from other companies - source Read More
category companyNews
from Reuters: Company News
BRIEF-Elan shares up 9 percent after says puts itself up for sale
June 14, 2013
DUBLIN, June 14 (Reuters) - Elan Corporation PLC : * Shares up 9 percent after says puts itself up for sale Read More
category companyNews
from Reuters: Company News
Irish drug company Elan puts itself up for sale
June 14, 2013
DUBLIN, June 14 (Reuters) - Irish drug company Elan said on Friday it will start a formal sale process in light of expressions of interest received to date. Read More
category companyNews
from Reuters: Company News
Royalty says most Elan shareholders to reject acquisition deals
June 14, 2013
* Royalty bid contingent on shareholders rejecting all votes Read More
category companyNews
from Reuters: Company News
BRIEF-Royalty says Elan Ads holders seen rejecting deals
June 14, 2013
DUBLIN, June 14 (Reuters) - Royalty Pharma: * Royalty pharma - says elan ads holders decisively vote against theravance and Read More
category companyNews
from Reuters: Company News
UPDATE 2-Royalty wins injunction as bid for Elan hits trouble
June 13, 2013
* U.S. firm says shareholders set to approve share buyback Read More
category companyNews
from Reuters: Company News
Royalty Pharma granted injuction as pursues Elan bid
June 13, 2013
DUBLIN, June 13 (Reuters) - Royalty Pharma was granted an injunction by the Irish High Court on Thursday that means its bid for Elan may not be doomed if some votes go against it at a meeting of the... Read More
category companyNews
from Reuters: Company News
Royalty bid for Elan in trouble ahead of key meeting
June 13, 2013
U.S.-based Royalty Pharma said on Thursday that it did not appear to have the backing of Elan shareholders in a vote that is set to decide the fate of its hostile bid of up to $8 billion for the Irish... Read More
from FOX News
UPDATE 1-Royalty bid for Elan in trouble ahead of key meeting
June 13, 2013
* U.S. firm says shareholders set to approve share buyback Read More
category companyNews
from Reuters: Company News
BRIEF-Royalty Pharma says offer for Elan may lapse
June 13, 2013
LONDON, June 13 (Reuters) - Royalty Pharma: * As of June 12 holders of 276 million Elan ADS,or over 70% of Elan ADS held in street name,voted on Elan proposals * Based on its review of those votes,it... Read More
category companyNews
from Reuters: Company News
NEWSMAKER-Divisive Elan boss Martin faces ownership showdown
June 13, 2013
* Elan CEO's grand plan on the line at shareholder meeting Read More
category companyNews
from Reuters: Company News
CORRECTED-(OFFICIAL)-Royalty wants Elan appeal heard next week
June 12, 2013
(Elan corrects statement to show share price has almost trebled, not more than trebled since Schuler's resignation announced, para 13) Read More
category companyNews
from Reuters: Company News
Royalty wants appeal over Elan bid heard next week
June 12, 2013
U.S.-based Royalty Pharma sought to have an appeal heard next week over conditions attached to its hostile bid for Irish drug firm Elan that threaten to scupper the $8 billion deal. Read More
from FOX News
Royalty pursuing hostile bid for Elan, fights Irish panel ruling
June 11, 2013
NEW YORK, June 11 (Reuters) - Royalty Pharma, pursuing a hostile $8 billion takeover of Irish drugmaker Elan Corp Plc, moved on Tuesday to make sure it is not blocked by a potential $200 million share... Read More
category companyNews
from Reuters: Company News
UPDATE 2-Elan says gets rival approaches, holds out for $15.50/shr cash
June 10, 2013
* Elan says new Royalty Pharma bid still undervalues company Read More
category companyNews
from Reuters: Company News
Elan voluntarily dismisses U.S. lawsuit against Royalty
June 10, 2013
Irish drug firm Elan Corp Plc voluntarily dismissed its U.S. lawsuit against Royalty Pharma , the U.S. investment firm which increased its offer to take over Elan last week, a court filing showed on... Read More
from FOX News
Elan voluntarily dismisses U.S. lawsuit against Royalty
June 10, 2013
NEW YORK, June 10 (Reuters) - Irish drug firm Elan Corp Plc voluntarily dismissed its U.S. lawsuit against Royalty Pharma, the U.S. investment firm which increased its offer to take over Elan last... Read More
category companyNews
from Reuters: Company News
US STOCKS SNAPSHOT-Wall St opens higher after credit outlook revised up
June 10, 2013
NEW YORK, June 10 (Reuters) - U.S. stocks rose on Monday after rating agency Standard & Poor's revised its U.S. credit outlook higher and as last week's employment report eased investor jitters that... Read More
category companyNews
from Reuters: Company News
US STOCKS-Wall St set to rise after credit outlook revised up
June 10, 2013
* Japan shares soar after GDP up 4.1 pct in first quarter Read More
category companyNews
from Reuters: Company News
Elan rejects fresh Royalty bid, assessing other interest
June 10, 2013
* Irish firm assessing several other unsolicited enquiries Read More
category companyNews
from Reuters: Company News
Royalty Pharma urges U.S. court to let Elan bid proceed
June 09, 2013
NEW YORK, June 9 (Reuters) - Investment partnership Royalty Pharma on Sunday urged a federal court in New York to allow it to proceed with a potential $8 billion bid for Irish drug company Elan Corp. Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here